Join
Live feed
·
INSIDERFilingvia Quantisnow
Aurinia Pharmaceuticals Inc logo

Chief Executive Officer Greenleaf Peter was granted 624,433 shares and sold $2,871,124 worth of shares (360,540 units at $7.96), increasing direct ownership by 17% to 1,788,945 units (SEC Form 4)

ByQuantisnow·Wall Street's wire, on your screen.

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track AUPH (Aurinia Pharmaceuticals Inc) and more on Quantisnow.

Chief Executive Officer Greenleaf Peter was granted 624,433 shares and sold $2,871,124 worth of shares (360,540 units at $7.96), increasing direct ownership by 17% to 1,788,945 units (SEC Form 4) | Quantisnow